Jazz Pharmaceuticals Shares Up 32.6% Since SmarTrend's Buy Recommendation (JAZZ)

SmarTrend identified an Uptrend for Jazz Pharmaceuticals (NASDAQ:JAZZ) on December 23rd, 2016 at $108.62. In approximately 3 months, Jazz Pharmaceuticals has returned 32.65% as of today's recent price of...